Life sciences industry veteran brings over two decades of clinical operations and data strategy expertise to accelerate market expansion and product innovation.
NEW YORK, NY, UNITED STATES, September 14, 2026 /EINPresswire.com/ — Auxilius, a leading clinical trial financial management platform for biotech and pharma companies, today announced the appointment of life sciences industry veteran Holly Leslie as Vice President, Investigator Grant Solutions. In her new role, Leslie will lead strategic initiatives across product strategy, go-to-market execution, and stakeholder engagement to bridge the gap between clinical operations and financial intelligence.
With over twenty years of experience spanning sponsor organizations, contract research organizations (CROs), and clinical software platforms, including prior leadership roles at Wyeth (now Pfizer), CFS Clinical (DrugDev/IQVIA), Medidata, and LedgerRun, Leslie brings deep expertise in operational workflows, investigator site engagement, and trial data management. At Auxilius, she will oversee the strategy and delivery of solutions that enable clinical trial sponsors to forecast, manage, and reconcile their investigator grants.
“Throughout my career, I’ve seen how deeply siloed clinical study management systems remain, leaving sponsors, sites, and CROs struggling to connect daily operational realities with financial oversight,” said Holly Leslie. “Joining Auxilius is the natural next step in everything I’ve been building toward over the past 20 years. Auxilius provides the unified picture the industry needs, connecting enrollment tracking, financial forecasting, and accounting insights into a single source of truth so clinical trial sites are treated as true research partners rather than isolated vendors.”
Leslie’s entry into clinical research was shaped by a personal experience in 1994 when her mother was diagnosed with glioblastoma, a fast-growing brain cancer. Participating in a clinical trial ignited Leslie’s personal mantra to “leave it better than you found it,” driving a 20-year career dedicated to modernizing trial execution.
Beyond unifying clinical operations and financial data, Leslie will focus on helping life sciences organizations navigate modern data analytics and pragmatic technology adoption.
“Applying automation to an efficient process magnifies efficiency, but applying it to an inefficient process just magnifies the inefficiency,” Leslie added. “The sweet spot for technology in clinical operations is removing routine administrative burdens so teams can focus on high-value decision-making. Auxilius was purpose-built to solve these core operational and financial visibility challenges.”
“We are thrilled to welcome Holly to the Auxilius leadership team,” said Adam Weisman, Chief Executive Officer at Auxilius. “Her deep domain expertise across site engagement, financial management, and investigator grants will be instrumental as we expand our platform capabilities and continue enabling sponsors to streamline trial execution.”
About Auxilius
Auxilius is the leading Clinical Trial Financial Management platform helping accounting, finance, and clinical operations teams at biotech and pharmaceutical companies plan, budget, and report their clinical trial costs.
Peter Kinchley
Auxilius
pkinchley@auxili.us
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
